Ji He

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ji He, Jiawei Li, Yanbiao Liu, Yan Li
Sperm-Associated Antigen 5 Knockout Reduces Doxorubicin and Docetaxel Resistance in Triple-Negative Breast Cancer MDA-MB-231 and BT549 Cells. Cancers 16 (7) (2024)
Ji He, Jiawei Li, Yanbiao Liu, Yan Li
Sperm-Associated Antigen 5 Knockout Reduces Doxorubicin and Docetaxel Resistance in Triple-Negative Breast Cancer MDA-MB-231 and BT549 Cells. Cancers 16 (7) (2024)
Ji He, Jiawei Li, Yanbiao Liu, Yan Li
Sperm-Associated Antigen 5 Knockout Reduces Doxorubicin and Docetaxel Resistance in Triple-Negative Breast Cancer MDA-MB-231 and BT549 Cells. Cancers 16 (7) (2024)
Jiawei Li, Eyleen L K Goh, Ji He, Yan Li, Zhimin Fan, Zhi-Gang Yu, Peng Yuan, Dong-Xu Liu
Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer. Biology 12 (5) (2023)
Ji He, Riya Biswas, Piyush Bugde, Jiawei Li, Dong-Xu Liu, Yan Li
Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery. Pharmaceutics 14 (5) (2022)
Ji He, Erika Fortunati, Dong-Xu Liu, Yan Li
Pleiotropic Roles of ABC Transporters in Breast Cancer. International journal of molecular sciences 22 (6) (2021)